Keytruda Combo! MSD Recruits German Biotech on Lymphoma PD-1 Trial
Affimed in Heidelberg (Germany) will fund and conduct a clinical trial to investigate the combination of…
January 26, 2016 - 2 minutes
MSD
Alphabody Platform for Cancer Draws in €260M Discovery Deal with MSD
Complix is a Belgian Immuno-Oncology Biotech with a proprietary Alphabody platform, which has now attracted…
January 7, 2016 - 2 minutes
Red Blood Cells to Carry Drugs? A US Start-Up Inspired by French Biotech to Focus on Rare Metabolic Disease
Erytech (France) is working on a drug-transportation system using red blood cells. Now US Rubius…
December 14, 2015 - 3 minutes
Merck Pulls out of Plans to Commercialize Cancer Drug After it Fails in Two Phase III Trials
Threshold Pharmaceuticals in the US has failed at getting its hypoxia prodrug evofosfamide through phase…
December 8, 2015 - 2 minutes
Ablynx richly rewarded for MSD’s Nanobody Proof in Immuno-Oncology
Ablynx - the Belgian nanobody biotech (which uses monoclonal antibodies of Alpacas), has now achieved…
October 15, 2015 - 2 minutes
Neurodegenerative Disease in the UK: Takeda, NIHR & UCL Research Collaboration
Takeda Cambridge (the UK subsidiary of global biotech Takeda Pharmaceuticals) will now collaborate with University…
October 15, 2015 - 2 minutes
What Happened this Week? Nobel prize slips through CRISPR’s fingers, inside iGEM’s Jamboree and €120M boost for Alzheimer’s research
Monday: Manfred Horst on MSD, Biosimilars, KEYTRUDA and Merck & Co.’s rich history Tuesday: An Insider’s experience…
October 10, 2015 - 1 minute
Rabbit Antibodies proven to be more specific than Mice in Immuno-oncology PD-L1 Research
Abcam is a Cambridge (UK) Biotech who have developed a monoclonal antibody (mAB) production platform…
October 8, 2015 - 3 minutes
Medicine Nobel Prize for Parasite Drug Discoveries which saved Billions
The Nobel Prize for Medicine and Physiology has been jointly awarded to Youyou Tu (the…
October 5, 2015 - 4 minutes
Manfred Horst on MSD, Biosimilars, KEYTRUDA and his Company’s rich history
Manfred Horst is a Director Business Development Europe and working from an office at MSD…
October 5, 2015 - 6 minutes
Review: The Future of Biomarkers in Immuno-Oncology
Immuno-oncology is a Biotech field that is more than just hype - it could solve…
August 31, 2015 - 5 minutes
Ablynx and MSD upgrade their €1.7Bn deal to gigantic €5.7Bn
Using camel antibodies as drugs, sounds crazy? Belgian Ablynx is exactly doing that and has…
July 27, 2015 - 2 minutes
